Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-12-26

Clinical Trial Update: The Use of Nutropin Depot in HIV-infected Adult Males [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Nutropin Depot in HIV-infected adult males shows the study has been withdrawn after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nutropin Depot (somatropin)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: HIV Infection | Phase 2, Phase 3 | Status: WITHDRAWN